# Dechra Pharmaceuticals Appoint Alison Platt as Non-Executive Director

- Link: https://www.directorstalkinterviews.com/dechra-pharmaceuticals-appoint-alison-platt-as-non-executive-director/412806864
- Published: 2020-02-28T07:31:23+00:00
- Author: Giles Arbor

**[Dechra Pharmaceuticals plc](https://www.directorstalkinterviews.com/ftse-company/dechra-pharmaceuticals/dph.l)**(
LON:DPH) has today announced that, with effect from 1 March 2020, Alison Platt will
take up a new position as a Non-Executive Director of the Company.

Alison’s appointment brings extensive experience of leadership in customer-driven
organisations across the healthcare, insurance and property sectors as well as international
experience she gained whilst leading a number of Bupa’s businesses across Asia, 
Southern and Eastern Europe and the Middle East. Between 2014 and 2018 Alison was
CEO of Countrywide.

Alison is currently a Non-Executive Director of [Tesco PLC](https://www.directorstalkinterviews.com/ftse-company/tesco-plc/tsco.l),
and Chair of Legal & General Financial Advice (LGFA), Legal and General’s newly 
launched financial advice business. She is a member of the steering group of the
Hampton-Alexander Review and was previously Chair of Opportunity Now. Alison was
awarded a CMG for services to the Foreign Office in 2011 after six years on the 
FCO Board and was a Non-Executive Director at Cable and Wireless Communications 
PLC.

> **Commenting on the appointment Tony Rice, Chairman, Dechra Pharmaceuticals said:**
> “On behalf of the Board and all stakeholders I am delighted to welcome Alison 
> to Dechra. She brings significant capabilities and experience both in Executive
> and Non-Executive roles which will strengthen the Board and provide continuity
> during the next phase of Dechra’s growth and development, as well as providing
> continuity over the forthcoming years with both the Senior Independent Director/
> Remuneration Committee Chairman and Audit Committee Chairman nine year terms expiring
> in 2022.”

Share on:
